Postoperative Nausea and Vomiting
📧 Sign up to get email alerts when something new happens for Postoperative Nausea and Vomiting.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-04-16FDA Approved: POSFREA — Supplemental Application (Avyxa Pharma, LLC)
The FDA approved a supplemental application for POSFREA (palonosetron) from Avyxa Pharma, LLC. The approval updates the product labeling to …
-
FDA approval · 2025-03-25FDA Approved: PALONOSETRON HYDROCHLORIDE — Supplemental Application (Eugia US LLC)
The FDA approved a supplemental application for palonosetron hydrochloride (generic) submitted by Eugia US LLC under ANDA204702, adding to t…
-
FDA approval · 2025-03-24FDA Approved: GRANISETRON HYDROCHLORIDE — Supplemental Application (Eugia US LLC)
FDA approved a supplemental application for granisetron hydrochloride submitted by Eugia US LLC.
-
FDA approval · 2025-03-24FDA Approved: PALONOSETRON HYDROCHLORIDE — Supplemental Application (Sagent Pharmaceuticals)
FDA approved a supplemental application for palonosetron hydrochloride submitted by Sagent Pharmaceuticals to support an approved indication…
-
FDA approval · 2025-03-17FDA Approved: GRANISOL — Original Application (Intra-Sana Laboratories)
FDA approved GRANISOL (granisetron hydrochloride) through an original ANDA submission by Intra-Sana Laboratories, authorizing the generic pr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-01-22FDA Approved: PROCHLORPERAZINE EDISYLATE — Supplemental Application (FOSUN PHARMA USA INC)
FDA approved a supplemental application for Prochlorperazine Edisylate by Fosun Pharma USA Inc.
-
FDA approval · 2025-01-22FDA Approved: PROCHLORPERAZINE MALEATE — Supplemental Application (Jubilant Cadista Pharmaceuticals Inc.)
FDA approved a supplemental application for Prochlorperazine Maleate from Jubilant Cadista Pharmaceuticals Inc., indicating an approval acti…
-
FDA approval · 2025-01-22FDA Approved: PROCHLORPERAZINE EDISYLATE — Supplemental Application (Eugia US LLC)
FDA approved a supplemental application for Prochlorperazine edisylate from Eugia US LLC. The approval pertains to a supplemental submission…
-
FDA approval · 2024-09-16FDA Approved: SANCUSO — Supplemental Application (Cumberland Pharmaceuticals Inc.)
The FDA approved a supplemental application for SANCUSO (granisetron) submitted by Cumberland Pharmaceuticals Inc.
-
FDA approval · 2024-09-13FDA Approved: PROCHLORPERAZINE EDISYLATE — Original Application (Somerset Therapeutics, LLC)
FDA approved the original ANDA for Prochlorperazine Edisylate from Somerset Therapeutics, LLC, authorizing its marketing as an antiemetic fo…
-
FDA approval · 2024-07-08FDA Approved: ONDANSETRON — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for a generic ondansetron hydrochloride product submitted by Fresenius Kabi USA, LLC.
-
FDA approval · 2024-05-06FDA Approved: SCOPOLAMINE — Original Application (Rhodes Pharmaceuticals L.P.)
FDA approved Rhodes Pharmaceuticals L.P.'s original application for scopolamine (generic), enabling marketing of a scopolamine product.
-
FDA approval · 2024-01-31FDA Approved: ONDANSETRON — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for ondansetron from Rising Pharma Holdings, Inc., indicating an approved change to the generic's la…
-
FDA approval · 2023-10-27FDA Approved: SCOPOLAMINE TRANSDERMAL SYSTEM — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a supplemental application for Scopolamine Transdermal System submitted by Padagis Israel Pharmaceuticals Ltd.
-
FDA approval · 2023-10-12FDA Approved: GRANISETRON HYDROCHLORIDE — Supplemental Application (Bionpharma Inc.)
FDA approved a supplemental application for Granisetron Hydrochloride by Bionpharma Inc., a generic antiemetic used to prevent chemotherapy-…
-
FDA approval · 2023-09-26FDA Approved: ONDANSETRON — Supplemental Application (Eugia US LLC)
FDA granted a supplemental approval for Ondansetron hydrochloride from Eugia US LLC, updating the status of this generic product. The action…
-
FDA approval · 2023-08-25FDA Approved: PALONOSETRON — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for Palonosetron hydrochloride from Apotex Corp., confirming its generic use. Palonosetron is used t…
-
FDA approval · 2023-08-14FDA Approved: PALONOSETRON HYDROCHLORIDE — Original Application (Meitheal Pharmaceuticals Inc.)
FDA approved Meitheal Pharmaceuticals' palonosetron hydrochloride generic under an Original Application for preventing postoperative nausea …
-
FDA approval · 2023-05-24FDA Approved: ONDANSETRON — Supplemental Application (Accord Healthcare, Inc.)
FDA approved a supplemental application for Ondansetron, manufactured by Accord Healthcare, Inc., signaling an update to its regulatory stat…
-
FDA approval · 2023-05-01FDA Approved: ONDANSETRON HYDROCHLORIDE — Supplemental Application (Onesource Specialty Pharma Limited)
The FDA approved a supplemental application for ondansetron hydrochloride from Onesource Specialty Pharma Limited, approving this generic an…
-
FDA approval · 2023-05-01FDA Approved: ONDANSETRON HYDROCHLORIDE — Supplemental Application (Onesource Specialty Pharma Limited)
FDA approved a supplemental application for ondansetron hydrochloride submitted by Onesource Specialty Pharma Limited (ANDA 078257). This ac…
-
FDA approval · 2023-04-26FDA Approved: ONDANSETRON — Supplemental Application (West-Ward Pharmaceuticals Corp)
FDA approved a supplemental application for ondansetron submitted by West-Ward Pharmaceuticals Corp, indicating an approved change to an exi…
-
FDA approval · 2023-04-04FDA Approved: PROCHLORPERAZINE MALEATE — Original Application (Bionpharma Inc.)
FDA approved an Original Application for Prochlorperazine Maleate from Bionpharma Inc., authorizing its marketing as a generic antiemetic.
-
FDA approval · 2023-03-17FDA Approved: PROCHLORPERAZINE MALEATE — Original Application (GLENMARK PHARMACEUTICALS INC., USA)
FDA approved Prochlorperazine maleate from Glenmark Pharmaceuticals under an Original Application; it is an antiemetic indicated to prevent …
-
FDA approval · 2022-12-06FDA Approved: SANCUSO — Supplemental Application (Cumberland Pharmaceuticals Inc.)
FDA approved Cumberland Pharmaceuticals' Supplemental Application for SANCUSO (granisetron), marking an updated approval for this antiemetic…